APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Human Insulin

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Human Insulin Market Analysis and Forecast 2026-2032

Report ID 173999900220 December 2025196 pages

Choose your research edition.

Industry ResearchHuman Insulin Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Insulin Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Human Insulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Insulin Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Insulin Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Human Insulin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Human Insulin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Human Insulin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Human Insulin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Human Insulin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Human Insulin include Sanofi, ELI Lilly, B. Braun, Ypsomed, Wockhardt, NOVO Nordisk, Julphar, Biodel and Biocon, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Human Insulin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Human Insulin, also provides the sales of main regions and countries. Of the upcoming market potential for Human Insulin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human Insulin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Human Insulin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Human Insulin sales, projected growth trends, production technology, application and end-user industry.

Human Insulin Segment by Company

Sanofi

ELI Lilly

B. Braun

Ypsomed

Wockhardt

NOVO Nordisk

Julphar

Biodel

Biocon

Becton, Dickinson

Human Insulin Segment by Type

Insulin Analogs and Biosimilars

Human Insulin Biologics

Human Insulin Segment by Application

Short Acting

Pre-Mix Insulin

Long Acting

Intermediate Acting

Human Insulin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Insulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Insulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Insulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Human Insulin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Human Insulin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Insulin sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Human Insulin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Insulin Analogs and Biosimilars Major Manufacturers Table 3. Human Insulin Biologics Major Manufacturers Table 4. Global Human Insulin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Short Acting Major Manufacturers Table 6. Pre-Mix Insulin Major Manufacturers Table 7. Long Acting Major Manufacturers Table 8. Intermediate Acting Major Manufacturers Table 9. Human Insulin Industry Trends Table 10. Human Insulin Industry Drivers Table 11. Human Insulin Industry Opportunities and Challenges Table 12. Human Insulin Industry Restraints Table 13. Global Human Insulin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Human Insulin Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Human Insulin Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Human Insulin Revenue Market Share by Region (2021-2026) Table 17. Global Human Insulin Revenue Market Share by Region (2027-2032) Table 18. Global Human Insulin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 19. Global Human Insulin Sales by Region (2021-2026) & (W Units) Table 20. Global Human Insulin Sales by Region (2027-2032) & (W Units) Table 21. Global Human Insulin Sales Market Share by Region (2021-2026) Table 22. Global Human Insulin Sales Market Share by Region (2027-2032) Table 23. Global Human Insulin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Human Insulin Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Human Insulin Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Human Insulin Sales Market Share by Manufacturers (2021-2026) Table 27. Global Human Insulin Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Human Insulin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Human Insulin Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Human Insulin Manufacturers, Product Type & Application Table 31. Global Human Insulin Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Human Insulin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Human Insulin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Human Insulin Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Human Insulin Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Human Insulin Revenue Market Share by Type (2021-2026) Table 38. Global Human Insulin Revenue Market Share by Type (2027-2032) Table 39. Global Human Insulin Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 40. Global Human Insulin Sales by Type (2021-2026) & (W Units) Table 41. Global Human Insulin Sales by Type (2027-2032) & (W Units) Table 42. Global Human Insulin Sales Market Share by Type (2021-2026) Table 43. Global Human Insulin Sales Market Share by Type (2027-2032) Table 44. Global Human Insulin Price by Type (2021-2026) & (US$/Unit) Table 45. Global Human Insulin Price by Type (2027-2032) & (US$/Unit) Table 46. Global Human Insulin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Human Insulin Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Human Insulin Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Human Insulin Revenue Market Share by Application (2021-2026) Table 50. Global Human Insulin Revenue Market Share by Application (2027-2032) Table 51. Global Human Insulin Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 52. Global Human Insulin Sales by Application (2021-2026) & (W Units) Table 53. Global Human Insulin Sales by Application (2027-2032) & (W Units) Table 54. Global Human Insulin Sales Market Share by Application (2021-2026) Table 55. Global Human Insulin Sales Market Share by Application (2027-2032) Table 56. Global Human Insulin Price by Application (2021-2026) & (US$/Unit) Table 57. Global Human Insulin Price by Application (2027-2032) & (US$/Unit) Table 58. Sanofi Company Information Table 59. Sanofi Business Overview Table 60. Sanofi Human Insulin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Sanofi Human Insulin Product Portfolio Table 62. Sanofi Recent Development Table 63. ELI Lilly Company Information Table 64. ELI Lilly Business Overview Table 65. ELI Lilly Human Insulin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. ELI Lilly Human Insulin Product Portfolio Table 67. ELI Lilly Recent Development Table 68. B. Braun Company Information Table 69. B. Braun Business Overview Table 70. B. Braun Human Insulin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. B. Braun Human Insulin Product Portfolio Table 72. B. Braun Recent Development Table 73. Ypsomed Company Information Table 74. Ypsomed Business Overview Table 75. Ypsomed Human Insulin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Ypsomed Human Insulin Product Portfolio Table 77. Ypsomed Recent Development Table 78. Wockhardt Company Information Table 79. Wockhardt Business Overview Table 80. Wockhardt Human Insulin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Wockhardt Human Insulin Product Portfolio Table 82. Wockhardt Recent Development Table 83. NOVO Nordisk Company Information Table 84. NOVO Nordisk Business Overview Table 85. NOVO Nordisk Human Insulin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. NOVO Nordisk Human Insulin Product Portfolio Table 87. NOVO Nordisk Recent Development Table 88. Julphar Company Information Table 89. Julphar Business Overview Table 90. Julphar Human Insulin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Julphar Human Insulin Product Portfolio Table 92. Julphar Recent Development Table 93. Biodel Company Information Table 94. Biodel Business Overview Table 95. Biodel Human Insulin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Biodel Human Insulin Product Portfolio Table 97. Biodel Recent Development Table 98. Biocon Company Information Table 99. Biocon Business Overview Table 100. Biocon Human Insulin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Biocon Human Insulin Product Portfolio Table 102. Biocon Recent Development Table 103. Becton, Dickinson Company Information Table 104. Becton, Dickinson Business Overview Table 105. Becton, Dickinson Human Insulin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Becton, Dickinson Human Insulin Product Portfolio Table 107. Becton, Dickinson Recent Development Table 108. North America Human Insulin Revenue by Type (2021-2026) & (US$ Million) Table 109. North America Human Insulin Revenue by Type (2027-2032) & (US$ Million) Table 110. North America Human Insulin Sales by Type (2021-2026) & (W Units) Table 111. North America Human Insulin Sales by Type (2027-2032) & (W Units) Table 112. North America Human Insulin Sales Price by Type (2021-2026) & (US$/Unit) Table 113. North America Human Insulin Sales Price by Type (2027-2032) & (US$/Unit) Table 114. North America Human Insulin Revenue by Application (2021-2026) & (US$ Million) Table 115. North America Human Insulin Revenue by Application (2027-2032) & (US$ Million) Table 116. North America Human Insulin Sales by Application (2021-2026) & (W Units) Table 117. North America Human Insulin Sales by Application (2027-2032) & (W Units) Table 118. North America Human Insulin Sales Price by Application (2021-2026) & (US$/Unit) Table 119. North America Human Insulin Sales Price by Application (2027-2032) & (US$/Unit) Table 120. North America Human Insulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. North America Human Insulin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 122. North America Human Insulin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 123. North America Human Insulin Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 124. North America Human Insulin Sales by Country (2021-2026) & (W Units) Table 125. North America Human Insulin Sales by Country (2027-2032) & (W Units) Table 126. North America Human Insulin Sales Price by Country (2021-2026) & (US$/Unit) Table 127. North America Human Insulin Sales Price by Country (2027-2032) & (US$/Unit) Table 128. United States Human Insulin Revenue (2021-2032) & (US$ Million) Table 129. Canada Human Insulin Revenue (2021-2032) & (US$ Million) Table 130. Europe Human Insulin Revenue by Type (2021-2026) & (US$ Million) Table 131. Europe Human Insulin Revenue by Type (2027-2032) & (US$ Million) Table 132. Europe Human Insulin Sales by Type (2021-2026) & (W Units) Table 133. Europe Human Insulin Sales by Type (2027-2032) & (W Units) Table 134. Europe Human Insulin Sales Price by Type (2021-2026) & (US$/Unit) Table 135. Europe Human Insulin Sales Price by Type (2027-2032) & (US$/Unit) Table 136. Europe Human Insulin Revenue by Application (2021-2026) & (US$ Million) Table 137. Europe Human Insulin Revenue by Application (2027-2032) & (US$ Million) Table 138. Europe Human Insulin Sales by Application (2021-2026) & (W Units) Table 139. Europe Human Insulin Sales by Application (2027-2032) & (W Units) Table 140. Europe Human Insulin Sales Price by Application (2021-2026) & (US$/Unit) Table 141. Europe Human Insulin Sales Price by Application (2027-2032) & (US$/Unit) Table 142. Europe Human Insulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Europe Human Insulin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 144. Europe Human Insulin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 145. Europe Human Insulin Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 146. Europe Human Insulin Sales by Country (2021-2026) & (W Units) Table 147. Europe Human Insulin Sales by Country (2027-2032) & (W Units) Table 148. Europe Human Insulin Sales Price by Country (2021-2026) & (US$/Unit) Table 149. Europe Human Insulin Sales Price by Country (2027-2032) & (US$/Unit) Table 150. Germany Human Insulin Revenue (2021-2032) & (US$ Million) Table 151. France Human Insulin Revenue (2021-2032) & (US$ Million) Table 152. U.K. Human Insulin Revenue (2021-2032) & (US$ Million) Table 153. Italy Human Insulin Revenue (2021-2032) & (US$ Million) Table 154. Netherlands Human Insulin Revenue (2021-2032) & (US$ Million) Table 155. China Human Insulin Revenue by Type (2021-2026) & (US$ Million) Table 156. China Human Insulin Revenue by Type (2027-2032) & (US$ Million) Table 157. China Human Insulin Sales by Type (2021-2026) & (W Units) Table 158. China Human Insulin Sales by Type (2027-2032) & (W Units) Table 159. China Human Insulin Sales Price by Type (2021-2026) & (US$/Unit) Table 160. China Human Insulin Sales Price by Type (2027-2032) & (US$/Unit) Table 161. China Human Insulin Revenue by Application (2021-2026) & (US$ Million) Table 162. China Human Insulin Revenue by Application (2027-2032) & (US$ Million) Table 163. China Human Insulin Sales by Application (2021-2026) & (W Units) Table 164. China Human Insulin Sales by Application (2027-2032) & (W Units) Table 165. China Human Insulin Sales Price by Application (2021-2026) & (US$/Unit) Table 166. China Human Insulin Sales Price by Application (2027-2032) & (US$/Unit) Table 167. Asia Human Insulin Revenue by Type (2021-2026) & (US$ Million) Table 168. Asia Human Insulin Revenue by Type (2027-2032) & (US$ Million) Table 169. Asia Human Insulin Sales by Type (2021-2026) & (W Units) Table 170. Asia Human Insulin Sales by Type (2027-2032) & (W Units) Table 171. Asia Human Insulin Sales Price by Type (2021-2026) & (US$/Unit) Table 172. Asia Human Insulin Sales Price by Type (2027-2032) & (US$/Unit) Table 173. Asia Human Insulin Revenue by Application (2021-2026) & (US$ Million) Table 174. Asia Human Insulin Revenue by Application (2027-2032) & (US$ Million) Table 175. Asia Human Insulin Sales by Application (2021-2026) & (W Units) Table 176. Asia Human Insulin Sales by Application (2027-2032) & (W Units) Table 177. Asia Human Insulin Sales Price by Application (2021-2026) & (US$/Unit) Table 178. Asia Human Insulin Sales Price by Application (2027-2032) & (US$/Unit) Table 179. Asia Human Insulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 180. Asia Human Insulin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 181. Asia Human Insulin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 182. Asia Human Insulin Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 183. Asia Human Insulin Sales by Country (2021-2026) & (W Units) Table 184. Asia Human Insulin Sales by Country (2027-2032) & (W Units) Table 185. Asia Human Insulin Sales Price by Country (2021-2026) & (US$/Unit) Table 186. Asia Human Insulin Sales Price by Country (2027-2032) & (US$/Unit) Table 187. Japan Human Insulin Revenue (2021-2032) & (US$ Million) Table 188. South Korea Human Insulin Revenue (2021-2032) & (US$ Million) Table 189. India Human Insulin Revenue (2021-2032) & (US$ Million) Table 190. Australia Human Insulin Revenue (2021-2032) & (US$ Million) Table 191. China Taiwan Human Insulin Revenue (2021-2032) & (US$ Million) Table 192. Southeast Asia Human Insulin Revenue (2021-2032) & (US$ Million) Table 193. SAMEA Human Insulin Revenue by Type (2021-2026) & (US$ Million) Table 194. SAMEA Human Insulin Revenue by Type (2027-2032) & (US$ Million) Table 195. SAMEA Human Insulin Sales by Type (2021-2026) & (W Units) Table 196. SAMEA Human Insulin Sales by Type (2027-2032) & (W Units) Table 197. SAMEA Human Insulin Sales Price by Type (2021-2026) & (US$/Unit) Table 198. SAMEA Human Insulin Sales Price by Type (2027-2032) & (US$/Unit) Table 199. SAMEA Human Insulin Revenue by Application (2021-2026) & (US$ Million) Table 200. SAMEA Human Insulin Revenue by Application (2027-2032) & (US$ Million) Table 201. SAMEA Human Insulin Sales by Application (2021-2026) & (W Units) Table 202. SAMEA Human Insulin Sales by Application (2027-2032) & (W Units) Table 203. SAMEA Human Insulin Sales Price by Application (2021-2026) & (US$/Unit) Table 204. SAMEA Human Insulin Sales Price by Application (2027-2032) & (US$/Unit) Table 205. SAMEA Human Insulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 206. SAMEA Human Insulin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 207. SAMEA Human Insulin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 208. SAMEA Human Insulin Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 209. SAMEA Human Insulin Sales by Country (2021-2026) & (W Units) Table 210. SAMEA Human Insulin Sales by Country (2027-2032) & (W Units) Table 211. SAMEA Human Insulin Sales Price by Country (2021-2026) & (US$/Unit) Table 212. SAMEA Human Insulin Sales Price by Country (2027-2032) & (US$/Unit) Table 213. Brazil Human Insulin Revenue (2021-2032) & (US$ Million) Table 214. Argentina Human Insulin Revenue (2021-2032) & (US$ Million) Table 215. Chile Human Insulin Revenue (2021-2032) & (US$ Million) Table 216. Colombia Human Insulin Revenue (2021-2032) & (US$ Million) Table 217. Peru Human Insulin Revenue (2021-2032) & (US$ Million) Table 218. Saudi Arabia Human Insulin Revenue (2021-2032) & (US$ Million) Table 219. Israel Human Insulin Revenue (2021-2032) & (US$ Million) Table 220. UAE Human Insulin Revenue (2021-2032) & (US$ Million) Table 221. Turkey Human Insulin Revenue (2021-2032) & (US$ Million) Table 222. Iran Human Insulin Revenue (2021-2032) & (US$ Million) Table 223. Egypt Human Insulin Revenue (2021-2032) & (US$ Million) Table 224. Key Raw Materials Table 225. Raw Materials Key Suppliers Table 226. Human Insulin Distributors List Table 227. Human Insulin Customers List Table 228. Research Programs/Design for This Report Table 229. Authors List of This Report Table 230. Secondary Sources Table 231. Primary Sources List of Figures Figure 1. Human Insulin Image Figure 2. Global Human Insulin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Insulin Market Size Share 2021 VS 2025 VS 2032 Figure 4. Insulin Analogs and Biosimilars Image Figure 5. Human Insulin Biologics Image Figure 6. Global Human Insulin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Human Insulin Market Size Share 2021 VS 2025 VS 2032 Figure 8. Short Acting Image Figure 9. Pre-Mix Insulin Image Figure 10. Long Acting Image Figure 11. Intermediate Acting Image Figure 12. Global Human Insulin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Human Insulin Revenue (2021-2032) & (US$ Million) Figure 14. Global Human Insulin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Human Insulin Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Human Insulin Revenue Market Share by Region (2021-2032) Figure 17. Global Human Insulin Sales (2021-2032) & (W Units) Figure 18. Global Human Insulin Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 19. Global Human Insulin Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Human Insulin Sales YoY (2021-2032) & (W Units) Figure 21. Europe Human Insulin Sales YoY (2021-2032) & (W Units) Figure 22. China Human Insulin Sales YoY (2021-2032) & (W Units) Figure 23. Asia (Excluding China) Human Insulin Sales YoY (2021-2032) & (W Units) Figure 24. South America, Middle East and Africa Human Insulin Sales YoY (2021-2032) & (W Units) Figure 25. Global Human Insulin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Human Insulin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Human Insulin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Human Insulin Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Human Insulin Revenue Market Share by Type (2021-2032) Figure 31. Global Human Insulin Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 32. Global Human Insulin Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Human Insulin Sales Market Share by Type (2021-2032) Figure 34. Global Human Insulin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Human Insulin Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Human Insulin Revenue Market Share by Application (2021-2032) Figure 37. Global Human Insulin Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 38. Global Human Insulin Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Human Insulin Sales Market Share by Application (2021-2032) Figure 40. North America Human Insulin Revenue Share by Type (2021-2032) Figure 41. North America Human Insulin Sales Share by Type (2021-2032) Figure 42. North America Human Insulin Revenue Share by Application (2021-2032) Figure 43. North America Human Insulin Sales Share by Application (2021-2032) Figure 44. North America Human Insulin Revenue Share by Country (2021-2032) Figure 45. North America Human Insulin Sales Share by Country (2021-2032) Figure 46. Europe Human Insulin Revenue Share by Type (2021-2032) Figure 47. Europe Human Insulin Sales Share by Type (2021-2032) Figure 48. Europe Human Insulin Revenue Share by Application (2021-2032) Figure 49. Europe Human Insulin Sales Share by Application (2021-2032) Figure 50. Europe Human Insulin Revenue Share by Country (2021-2032) Figure 51. Europe Human Insulin Sales Share by Country (2021-2032) Figure 52. China Human Insulin Revenue Share by Type (2021-2032) Figure 53. China Human Insulin Sales Share by Type (2021-2032) Figure 54. China Human Insulin Revenue Share by Application (2021-2032) Figure 55. China Human Insulin Sales Share by Application (2021-2032) Figure 56. Asia Human Insulin Revenue Share by Type (2021-2032) Figure 57. Asia Human Insulin Sales Share by Type (2021-2032) Figure 58. Asia Human Insulin Revenue Share by Application (2021-2032) Figure 59. Asia Human Insulin Sales Share by Application (2021-2032) Figure 60. Asia Human Insulin Revenue Share by Country (2021-2032) Figure 61. Asia Human Insulin Sales Share by Country (2021-2032) Figure 62. SAMEA Human Insulin Revenue Share by Type (2021-2032) Figure 63. SAMEA Human Insulin Sales Share by Type (2021-2032) Figure 64. SAMEA Human Insulin Revenue Share by Application (2021-2032) Figure 65. SAMEA Human Insulin Sales Share by Application (2021-2032) Figure 66. SAMEA Human Insulin Revenue Share by Country (2021-2032) Figure 67. SAMEA Human Insulin Sales Share by Country (2021-2032) Figure 68. Human Insulin Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Human Insulin Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Insulin Analogs and Biosimilars
  • Human Insulin Biologics
Applications
  • Short Acting
  • Pre-Mix Insulin
  • Long Acting
  • Intermediate Acting
Companies covered
  • Sanofi
  • ELI Lilly
  • B. Braun
  • Ypsomed
  • Wockhardt
  • NOVO Nordisk
  • Julphar
  • Biodel
  • Biocon
  • Becton, Dickinson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Human Insulin Market by Type
  3. 1.2.1 Global Human Insulin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Insulin Analogs and Biosimilars
  5. 1.2.3 Human Insulin Biologics
  6. 1.3 Human Insulin Market by Application
  7. 1.3.1 Global Human Insulin Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Short Acting
  9. 1.3.3 Pre-Mix Insulin
  10. 1.3.4 Long Acting
  11. 1.3.5 Intermediate Acting
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Human Insulin Market Dynamics
  1. 2.1 Human Insulin Industry Trends
  2. 2.2 Human Insulin Industry Drivers
  3. 2.3 Human Insulin Industry Opportunities and Challenges
  4. 2.4 Human Insulin Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Human Insulin Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Human Insulin Revenue by Region
  3. 3.2.1 Global Human Insulin Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Human Insulin Revenue by Region (2021-2026)
  5. 3.2.3 Global Human Insulin Revenue by Region (2027-2032)
  6. 3.2.4 Global Human Insulin Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Human Insulin Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Human Insulin Sales by Region
  9. 3.4.1 Global Human Insulin Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Human Insulin Sales by Region (2021-2026)
  11. 3.4.3 Global Human Insulin Sales by Region (2027-2032)
  12. 3.4.4 Global Human Insulin Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Human Insulin Revenue by Manufacturers
  2. 4.1.1 Global Human Insulin Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Human Insulin Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Human Insulin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Human Insulin Sales by Manufacturers
  6. 4.2.1 Global Human Insulin Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Human Insulin Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Human Insulin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Human Insulin Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Human Insulin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Human Insulin Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Human Insulin Manufacturers, Product Type & Application
  13. 4.7 Global Human Insulin Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Human Insulin Market CR5 and HHI
  16. 4.8.2 2025 Human Insulin Tier 1, Tier 2, and Tier 3
5 Human Insulin Market by Type
  1. 5.1 Global Human Insulin Revenue by Type
  2. 5.1.1 Global Human Insulin Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Human Insulin Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Human Insulin Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Human Insulin Sales by Type
  6. 5.2.1 Global Human Insulin Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Human Insulin Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Human Insulin Sales Market Share by Type (2021-2032)
  9. 5.3 Global Human Insulin Price by Type
6 Human Insulin Market by Application
  1. 6.1 Global Human Insulin Revenue by Application
  2. 6.1.1 Global Human Insulin Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Human Insulin Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Human Insulin Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Human Insulin Sales by Application
  6. 6.2.1 Global Human Insulin Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Human Insulin Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Human Insulin Sales Market Share by Application (2021-2032)
  9. 6.3 Global Human Insulin Price by Application
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Human Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Human Insulin Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 ELI Lilly
  8. 7.2.1 ELI Lilly Company Information
  9. 7.2.2 ELI Lilly Business Overview
  10. 7.2.3 ELI Lilly Human Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 ELI Lilly Human Insulin Product Portfolio
  12. 7.2.5 ELI Lilly Recent Developments
  13. 7.3 B. Braun
  14. 7.3.1 B. Braun Company Information
  15. 7.3.2 B. Braun Business Overview
  16. 7.3.3 B. Braun Human Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 B. Braun Human Insulin Product Portfolio
  18. 7.3.5 B. Braun Recent Developments
  19. 7.4 Ypsomed
  20. 7.4.1 Ypsomed Company Information
  21. 7.4.2 Ypsomed Business Overview
  22. 7.4.3 Ypsomed Human Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Ypsomed Human Insulin Product Portfolio
  24. 7.4.5 Ypsomed Recent Developments
  25. 7.5 Wockhardt
  26. 7.5.1 Wockhardt Company Information
  27. 7.5.2 Wockhardt Business Overview
  28. 7.5.3 Wockhardt Human Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Wockhardt Human Insulin Product Portfolio
  30. 7.5.5 Wockhardt Recent Developments
  31. 7.6 NOVO Nordisk
  32. 7.6.1 NOVO Nordisk Company Information
  33. 7.6.2 NOVO Nordisk Business Overview
  34. 7.6.3 NOVO Nordisk Human Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 NOVO Nordisk Human Insulin Product Portfolio
  36. 7.6.5 NOVO Nordisk Recent Developments
  37. 7.7 Julphar
  38. 7.7.1 Julphar Company Information
  39. 7.7.2 Julphar Business Overview
  40. 7.7.3 Julphar Human Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Julphar Human Insulin Product Portfolio
  42. 7.7.5 Julphar Recent Developments
  43. 7.8 Biodel
  44. 7.8.1 Biodel Company Information
  45. 7.8.2 Biodel Business Overview
  46. 7.8.3 Biodel Human Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Biodel Human Insulin Product Portfolio
  48. 7.8.5 Biodel Recent Developments
  49. 7.9 Biocon
  50. 7.9.1 Biocon Company Information
  51. 7.9.2 Biocon Business Overview
  52. 7.9.3 Biocon Human Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Biocon Human Insulin Product Portfolio
  54. 7.9.5 Biocon Recent Developments
  55. 7.10 Becton, Dickinson
  56. 7.10.1 Becton, Dickinson Company Information
  57. 7.10.2 Becton, Dickinson Business Overview
  58. 7.10.3 Becton, Dickinson Human Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Becton, Dickinson Human Insulin Product Portfolio
  60. 7.10.5 Becton, Dickinson Recent Developments
8 North America
  1. 8.1 North America Human Insulin Market Size by Type
  2. 8.1.1 North America Human Insulin Revenue by Type (2021-2032)
  3. 8.1.2 North America Human Insulin Sales by Type (2021-2032)
  4. 8.1.3 North America Human Insulin Price by Type (2021-2032)
  5. 8.2 North America Human Insulin Market Size by Application
  6. 8.2.1 North America Human Insulin Revenue by Application (2021-2032)
  7. 8.2.2 North America Human Insulin Sales by Application (2021-2032)
  8. 8.2.3 North America Human Insulin Price by Application (2021-2032)
  9. 8.3 North America Human Insulin Market Size by Country
  10. 8.3.1 North America Human Insulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Human Insulin Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Human Insulin Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Human Insulin Market Size by Type
  2. 9.1.1 Europe Human Insulin Revenue by Type (2021-2032)
  3. 9.1.2 Europe Human Insulin Sales by Type (2021-2032)
  4. 9.1.3 Europe Human Insulin Price by Type (2021-2032)
  5. 9.2 Europe Human Insulin Market Size by Application
  6. 9.2.1 Europe Human Insulin Revenue by Application (2021-2032)
  7. 9.2.2 Europe Human Insulin Sales by Application (2021-2032)
  8. 9.2.3 Europe Human Insulin Price by Application (2021-2032)
  9. 9.3 Europe Human Insulin Market Size by Country
  10. 9.3.1 Europe Human Insulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Human Insulin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Human Insulin Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Human Insulin Market Size by Type
  2. 10.1.1 China Human Insulin Revenue by Type (2021-2032)
  3. 10.1.2 China Human Insulin Sales by Type (2021-2032)
  4. 10.1.3 China Human Insulin Price by Type (2021-2032)
  5. 10.2 China Human Insulin Market Size by Application
  6. 10.2.1 China Human Insulin Revenue by Application (2021-2032)
  7. 10.2.2 China Human Insulin Sales by Application (2021-2032)
  8. 10.2.3 China Human Insulin Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Human Insulin Market Size by Type
  2. 11.1.1 Asia Human Insulin Revenue by Type (2021-2032)
  3. 11.1.2 Asia Human Insulin Sales by Type (2021-2032)
  4. 11.1.3 Asia Human Insulin Price by Type (2021-2032)
  5. 11.2 Asia Human Insulin Market Size by Application
  6. 11.2.1 Asia Human Insulin Revenue by Application (2021-2032)
  7. 11.2.2 Asia Human Insulin Sales by Application (2021-2032)
  8. 11.2.3 Asia Human Insulin Price by Application (2021-2032)
  9. 11.3 Asia Human Insulin Market Size by Country
  10. 11.3.1 Asia Human Insulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Human Insulin Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Human Insulin Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Human Insulin Market Size by Type
  2. 12.1.1 SAMEA Human Insulin Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Human Insulin Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Human Insulin Price by Type (2021-2032)
  5. 12.2 SAMEA Human Insulin Market Size by Application
  6. 12.2.1 SAMEA Human Insulin Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Human Insulin Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Human Insulin Price by Application (2021-2032)
  9. 12.3 SAMEA Human Insulin Market Size by Country
  10. 12.3.1 SAMEA Human Insulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Human Insulin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Human Insulin Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Human Insulin Value Chain Analysis
  2. 13.1.1 Human Insulin Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Human Insulin Production Mode & Process
  6. 13.2 Human Insulin Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Human Insulin Distributors
  9. 13.2.3 Human Insulin Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst